Filter Results :

Your search for Pharma returned 24643 reports

Sort by


Squalene Market by Type (Animal-Sourced & Vegetable-Sourced) and End-Use Industry (Cosmetics, Pharmaceuticals & Food) - Global Forecasts to 2021

13 May 2016  |  Published by:  MarketsandMarkets
Squalene market to reach USD 211.7 billion by 2021 The global squalene market is estimated to reach a market size of USD 211.7 million by 2021 and is projected to register a CAGR of 10.2% between 2016 and 2021. Squalene has many beneficial properties such as anti-oxidation, anti-aging, stre...

$ 4,650.00

Read More

Empty Capsules Market by Product (Gelatin (Porcine, Bovine, Bone Meal), Non-Gelatin (HPMC, Pullulan)), Application (Antibiotics, Vitamins, Anti-Inflammatory, Ant anemic) & End User (Pharmaceutical, Nutraceutical, Cosmetics) - Global Forecast to 2021

13 May 2016  |  Published by:  MarketsandMarkets
The global empty capsules market is estimated to reach USD 2.13 billion by 2021, growing at a CAGR of 7.2% during the forecast period (2016–2021). The factors driving this market are rapidly increasing aging population, growing consumer preference towards capsule-based formulations, and rising...

$ 4,650.00

Read More

Homogenizers Market by Type (Ultrasonic, Pressure, Mechanical), by Valve Technology (Single-valve Assembly, Two-valve Assembly), by Application (Food & Dairy, Cosmetics, Pharmaceuticals, Chemical Processing, Biotechnology), by Geography - Forecast to 2021

10 May 2016  |  Published by:  MarketsandMarkets
Growing demand for novel food & beverage products to drive the market for homogenizers The global market for homogenizers is projected to grow from USD 1.53 billion in 2016 to reach USD 1.94 billion by 2021, at an estimated CAGR of 4.92% from 2016 to 2021. The homogenizers market is dri...

$ 4,650.00

Read More

Costa Rica Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The approved loan from the World Bank will help improve the institutional management and organisation of healthcare delivery in Costa Rica's public healthcare sector, as well as enhance the financial sustainability of Costa Rica's universal health insurance scheme. This investment in...

$ 1,295.00

Read More

Belarus Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Belarus poses challenges for multinational drugmakers given government initiatives to reduce the reliance on medicinal imports. The weak ruble has seen prices of foreign medicines rise to unaffordable levels and has led to state intervention in the form of domestic bias in the medici...

$ 1,295.00

Read More

Cote d'Ivoire Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Côte d'Ivoire's pharmaceutical and healthcare markets will be given a boost following signs of impressive economic growth and the government's ongoing commitment to universal healthcare provision.  We expect opportunities for innovative drugmakers to come into fruition over the ...

$ 1,295.00

Read More

China Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Ongoing challenges facing multinational pharmaceutical firms in China will persist into 2016. This includes pricing pressures on off-patented pharmaceuticals, as authorities look to meet the unmet medical need in the country by expanding access to medicines while curbing rising healt...

$ 1,295.00

Read More

Belgium Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Belgium offers a stable pharmaceutical market with high per capita spending on medicines. However, drugmakers will increasingly find the government less willing to reimburse expensive, innovative medicines as it struggles to hit its fiscal targets. Headline Expenditure Projections ...

$ 1,295.00

Read More

Italy Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: SSN pharmaceutical expenditure will decline in 2016 - intensifying the revenue pressures for drugmakers and pharmacies in Italy, and increasing out-of-pocket costs for the population. The government remains committed to remaining under the 3% of GDP budget deficit limit and using any...

$ 1,295.00

Read More

Brazil Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The current state of political uncertainty will not shake Brazil's leading position as Latin America's largest pharmaceutical and healthcare market. The Brazilian government has been committed to improving the population's access to healthcare for decades. Having said this, Brazil's ...

$ 1,295.00

Read More

India Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The tough operating environment for multinational drugmakers in India will see little improvement over the medium term. Designated as a 'Priority Watch List Country' for PhRMA's Special 301 submission for 2016, the issues raised largely mirrored those touched upon in the 2015 submiss...

$ 1,295.00

Read More

Bulgaria Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The vote of no confidence against Bulgaria's government, despite being unsuccessful, has highlighted the dissatisfaction of a large proportion of the population with proposed healthcare reforms. A number of recent controversies have lowered the public's opinion of its governance, but new l...

$ 1,295.00

Read More

Botswana Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The growth of Botswana's pharmaceutical and healthcare markets will remain limited over the coming years as multinational drugmakers are unlikely to establish a direct manufacturing presence within the country. The government's ongoing commitment to alleviating the overwhelming H...

$ 1,295.00

Read More

Cuba Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Pharmaceutical investment and commercial opportunities in Cuba will increase at a slow pace over the forecast period. Cuba's biotechnology industry is set to benefit from the lifting of the US trade embargo, while the world-class Cuban medical research and manufacturing capacity will...

$ 1,295.00

Read More

Finland Pharmaceuticals and Healthcare Report

04 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Finland's economy is set to expand at the slowest rate in the eurozone in 2017. Reforms aimed at tackling its uncompetitive labour market will be insufficient to solve its bleak economic situation. This will force the government to make cost savings, with the pharmaceutical and healt...

$ 1,295.00

Read More
Total 24643 records.